The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Pattern discovery and cancer gene identification in integrated cancer genomic data
Open accessAbstract
Large-scale integrated cancer genome characterization efforts including the cancer genome atlas and the cancer cell line encyclopedia have created unprecedented opportunities to study cancer biology in the context of knowing the entire catalog of genetic alterations. A clinically important challenge is to discover cancer subtypes and their molecular drivers in a comprehensive genetic context. Curtis et al. [ Nature (2012) 486(7403):346–352] has recently shown that integrative clustering of copy number and gene expression in 2,000 breast tumors reveals novel subgroups beyond the classic expression subtypes that show distinct clinical outcomes. To extend the scope of integrative analysis for the inclusion of somatic mutation data by massively parallel sequencing, we propose a framework for joint modeling of discrete and continuous variables that arise from integrated genomic, epigenomic, and transcriptomic profiling. The core idea is motivated by the hypothesis that diverse molecular phenotypes can be predicted by a set of orthogonal latent variables that represent distinct molecular drivers, and thus can reveal tumor subgroups of biological and clinical importance. Using the cancer cell line encyclopedia dataset, we demonstrate our method can accurately group cell lines by their cell-of-origin for several cancer types, and precisely pinpoint their known and potential cancer driver genes. Our integrative analysis also demonstrates the power for revealing subgroups that are not lineage-dependent, but consist of different cancer types driven by a common genetic alteration. Application of the cancer genome atlas colorectal cancer data reveals distinct integrated tumor subtypes, suggesting different genetic pathways in colon cancer progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Along with the introduction of high-throughput technologies and the availability of multi-omics data derived from a number of samples, a large set of multi-omics data integrative tools and methods have been reported for the discovery of biomarkers.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [98]
In the citing paper
“These methods can be divided into categories, such as Bayesian integration (e.g., Pathway Recognition Algorithm using Data Integration on Genomic Models (PARADIGM) [97], iClusterPlus [98], Patient-specific data fusion (PSDF) [99]), network and pathway integration (e.g., Similarity network fusion (SNF) [100], PaintOmics [101], MultiGSEA [102], multi-omics gene-set analysis (MOGSA) [103], Cytoscape”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [98]
Citations
Cites
Regression shrinkage and selection via the lasso
Tibshirani, R. (1996) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1996.tb02080.x · Cited by 51,482
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Atomic Decomposition by Basis Pursuit
Chen, S. S., Donoho, D. L., & Saunders, M. A. (1998) · SIAM Journal on Scientific Computing · doi:10.1137/s1064827596304010 · Cited by 6,734
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1038/nature10166 · DOI · Paper page
- 10.1101/gr.120477.111 · DOI
Cited by
Sorted by citations
Items 101–200 of 474
Mallik, S., & Zhao, Z. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby120 · Cited by 46
“• K - m e a n s , a p r i o r i a l g o r i t h m , J o i n t N M F [ 91 ] , [ 92 ] , i C l u s t e r [ 94 ] , i C l u s t e r + [ 95 ] , s M B P L S [ 101 ] , S N P L S [ 102 ] , C N A m e t [ 23 ] , e t c .”
MethodMeng, J., Jiang, A., Lu, X., Gu, D., Ge, Q., Bai, S., Zhou, Y., Zhou, J., Hao, Z., Yan, F., et al. (2023) · iMeta · doi:10.1002/imt2.147 · Cited by 43
“For the CNAs, we condensed the genomic segments as described in the literature [33].”
MethodSynthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning
Cai, Z., Apolinário, S., Baião, A. R., Pacini, C., Sousa, M. D., Vinga, S., Reddel, R. R., Robinson, P. J., Garnett, M. J., Zhong, Q., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54771-4 · Cited by 49
“From the list of methods we evaluated, we considered iClusterPlus 43 , JAMIE 18 , scVAEIT 44 , and moCluster 45 (Supplementary Data 6, see Methods) .”
Lee, H., Flaherty, P., & Ji, H. P. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-54 · Cited by 42
“We also demonstrated that the predictive power was relatively improved using our integrative analysis approach (Table 2) as several other studies have demonstrated previously [24-29].”
BackgroundResultDeep Subspace Mutual Learning for cancer subtypes prediction
Yang, B., Xin, T., Pang, S., Wang, M., & Wang, Y.-J. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab625 · Cited by 40
Mo, Q., Li, R., Adeegbe, D. O., Peng, G., & Chan, K. S. (2020) · Communications Biology · doi:10.1038/s42003-020-01491-2 · Cited by 41
Self-citationPark, Y., Heider, D., & Hauschild, A.-C. (2021) · Cancers · doi:10.3390/cancers13133148 · Cited by 46
“Two of the most vibrantly evolving areas are systems biology and machine learning which tackle different tasks such as understanding the cancer pathways [9], finding crucial genes in pathways [22,53], or predicting functions of unidentified or understudied genes [54].”
BackgroundJSNMF enables effective and accurate integrative analysis of single-cell multiomics data
Ma, Y., Sun, Z., Zeng, P., Zhang, W., & Lin, Z. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac105 · Cited by 40
Computational Analysis of Phosphoproteomics Data in Multi‐Omics Cancer Studies
Mantini, G., Pham, T. V., Piersma, S. R., & Jiménez, C. R. (2020) · PROTEOMICS · doi:10.1002/pmic.201900312 · Cited by 38
Goodrich, J. A., Wang, H., Jia, Q., Stratakis, N., Zhao, Y., Maître, L., Bustamante, M., Vafeiadi, M., Aung, M. T., Andrušaitytė, S., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108930 · Cited by 41
“…consensus clustering; Gabasova et al., 2017; Jovanovski and Kocarev, 2019; Kirk et al., 2012; Lock et al., 2013; Luo et al., 2017; Min et al., 2018; Mo et al., 2013; Shen et al., 2009) and network and Bayesian network analysis (e.g., XMWAS; Friedman, 2003; Heckerman, 1998; Liu et al., 2012; Uppal…”
Labory, J., Fierville, M., Ait-El-Mkadem, S., Bannwarth, S., Paquis‐Flucklinger, V., & Bottini, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.590842 · Cited by 41
“, 2014), iClusterPlus (Mo et al., 2013), or Pathway Recognition Algorithm using Data Integration on Genomic Models (PARADIGM) (Vaske et al.”
MethodArora, A., Olshen, A. B., Seshan, V., & Shen, R. (2020) · Genome Medicine · doi:10.1186/s13073-020-00804-8 · Cited by 38
Self-citationBueschbell, B., Caniceiro, A. B., Suzano, P. M. S., Machuqueiro, M., Rosário‐Ferreira, N., & Moreira, I. S. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100811 · Cited by 38
Heterogeneous data integration methods for patient similarity networks
Gliozzo, J., Mesiti, M., Notaro, M., Petrini, A., Patak, A., Gallardo, A. P., Paccanaro, A., Valentini, G., & Casiraghi, E. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac207 · Cited by 38
Ruan, P., Todd, J. L., Zhao, H., Liu, Y., Vinisko, R., Söllner, J. F., Schmid, R., Kaner, R. J., Luckhardt, T., Neely, M. L., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02435-0 · Cited by 43
“The scSNF method was compared to the alternative integrative clustering methods iCluster+ [31] and iClusterBayes [32].”
Song, W., Wang, W., & Dai, D. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab398 · Cited by 36
Fertig, E. J., Marković, A. K., Danilova, L., Gaykalova, D. A., Cope, L., Chung, C. H., Ochs, M. F., & Califano, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078127 · Cited by 35
“We applied the CoGAPS matrix factorization algorithm to simultaneously infer patterns associated with meta-pathway activity from a combined data matrix D containing gene expression data for nE genes and log transformed b values for DNA methylation of nM genes for the same set of m samples, analogous to [10,11].”
Systems Medicine: The Future of Medical Genomics, Healthcare, and Wellness
Saqi, M. A. S., Pellet, J., Balaur, I., Mazein, A., Ballereau, S. J., Meulder, B. D., & Auffray, C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3283-2_3 · Cited by 39
A latent unknown clustering integrating multi-omics data (LUCID) with phenotypic traits
Peng, C., Wang, J., Asante, I., Louie, S. G., Jin, R., Chatzi, L., Casey, G., Thomas, D. C., & Conti, D. V. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz667 · Cited by 35
Drug Target Prediction by Multi-View Low Rank Embedding
Li, L., & Cai, M. (2017) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2017.2706267 · Cited by 35
“Multi-view approaches can be roughly divided in three families, depending on whether they linearly combine the multiple loss functions in different views [14], [15], [16], or combine multiple graphs with an optimal combination of weights for different purposes [17], [18], [19], [20], or conform different view-specific…”
BackgroundHierarchical Maximum Likelihood Clustering Approach
Sharma, A. K., Boroevich, K. A., Shigemizu, D., Kamatani, Y., Kubo, M., & Tsunoda, T. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2542212 · Cited by 34
Vlachavas, E., Bohn, J. R., Ückert, F., & Nürnberg, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062822 · Cited by 37
Uniform Projection for Multi-View Learning
Zhang, Z., Zhai, Z., & Li, L. (2016) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2016.2601608 · Cited by 33
Cancer subtyping with heterogeneous multi-omics data via hierarchical multi-kernel learning
Wei, Y., Li, L., Zhao, X., Yang, H., Sa, J., Cao, H., & Cui, Y. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac488 · Cited by 33
Unsupervised discovery of phenotype-specific multi-omics networks
Shi, W. J., Zhuang, Y., Russell, P. H., Hobbs, B. D., Parker, M. M., Castaldi, P. J., Rudra, P., Vestal, B. E., Hersh, C. P., Saba, L. M., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz226 · Cited by 34
On fusion methods for knowledge discovery from multi-omics datasets
Baldwin, E., Han, J., Luo, W., Zhou, J. J., An, L., Liu, J., Zhang, H. H., & Li, H. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.02.011 · Cited by 33
“iCluster has been used to identify known and novel subtypes of breast and lung cancers from concordant DNA copy number changes and gene expression [36] while iCluster+ has accurately grouped cell lines by their cell-of-origin for several cancer types using genomic, epigenomic and transcriptomic profiling [37].”
BackgroundMethodMulti-view clustering for multi-omics data using unified embedding
Mitra, S., Saha, S., & Hasanuzzaman, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-70229-1 · Cited by 32
“Mo et al. developed iClusterPlus 46 , the iCluster extension, which uses linear regression models to learn different properties of omics data.”
MethodRole of Artificial Intelligence in Drug Discovery and Target Identification in Cancer
Sharma, V., Singh, A. K., Chauhan, S., Sharma, P. K., Chaudhary, S., Sharma, A., Porwal, O., & Fuloria, N. K. (2023) · Current Drug Delivery · doi:10.2174/1567201821666230905090621 · Cited by 36
Multi-Omics Data Analysis Identifies Prognostic Biomarkers across Cancers
Karaman, E. D., & Işık, Z. (2023) · Medical Sciences · doi:10.3390/medsci11030044 · Cited by 31
“[44] performed a statistical integrative clustering analysis (iCluster+) using exome sequence, DNA copy number, promoter methylation, and mRNA expression data of TCGA colorectal carcinoma.”
MethodHai, Y., Wei, Q., Zhong, X., Yang, H., & Li, B. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw662 · Cited by 30
Integrating Epigenomics into the Understanding of Biomedical Insight
Han, Y., & He, X. (2016) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s38427 · Cited by 32
A hierarchical clustering and data fusion approach for disease subtype discovery
Pfeifer, B., & Schimek, M. G. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103636 · Cited by 31
Hopp, L., Loeffler‐Wirth, H., Galle, J., & Binder, H. (2018) · Epigenomics · doi:10.2217/epi-2017-0140 · Cited by 30
Simultaneous discovery of cancer subtypes and subtype features by molecular data integration
Van, T. L., van Leeuwen, M., Fierro, A. C., Maeyer, D. D., den Eynden, J. V., Verbeke, L. P. C., Raedt, L. D., Kathleen Marchal, D., & Nijssen, S. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw434 · Cited by 29
A survey on data integration for multi-omics sample clustering
Lovino, M., Randazzo, V., Ciravegna, G., Barbiero, P., Ficarra, E., & Cirrincione, G. (2021) · Neurocomputing · doi:10.1016/j.neucom.2021.11.094 · Cited by 31
Invention of 3Mint for feature grouping and scoring in multi-omics
Yazıcı, M. Ü., Marron, J. S., Bakır-Güngör, B., Zou, F., & Yousef, M. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1093326 · Cited by 29
“Joint Non-negative Matrix Factorization (NMF) (Zhang et al., 2012), iCluster+ (Mo et al., 2013), Multiple Dataset Integration (MDI) (Kirk et al., 2012) and JIVE (Lock et al., 2013) have been proposed as unsupervised methods; and supervised approaches such as Network-based integration of multi-omics…”
MethodZhu, H., Li, G., & Lock, E. F. (2018) · Biostatistics · doi:10.1093/biostatistics/kxy052 · Cited by 29
“The iCluster+ approach [Mo et al., 2013], which enhanced iCluster, provides a feasible approach to the clustering of multi-source data with both discrete and continuous values.”
MethodIntegrative clustering methods for multi‐omics data
Zhang, X., Zhou, Z., Xu, H., & Liu, C. (2021) · Wiley Interdisciplinary Reviews Computational Statistics · doi:10.1002/wics.1553 · Cited by 31
Zhang, L., & Zhang, S. (2019) · IEEE Transactions on Fuzzy Systems · doi:10.1109/tfuzz.2019.2928518 · Cited by 28
“For example, iCluster [16] and its successor iCluster+ [17] assume that data originates from a low-dimension representation and represent it by a common low-dimension data matrix Z.”
BackgroundMethodPAMOGK: a pathway graph kernel-based multiomics approach for patient clustering
Tepeli, Y. I., Ünal, A. B., Akdemir, F. M., & Taştan, Ö. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa655 · Cited by 33
Statistical contributions to bioinformatics: Design, modelling, structure learning and integration
Morris, J. S., & Baladandayuthapani, V. (2017) · Statistical Modelling · doi:10.1177/1471082x17698255 · Cited by 30
“Mo et al. (2013) and Shen et al. (2013) proposed a clustering model ‘iCluster’, which uses a joint latent variable model to cluster samples into tumour subtypes.”
BackgroundUsing association signal annotations to boost similarity network fusion
Ruan, P., Wang, Y., Shen, R., & Wang, S. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz124 · Cited by 28
Self-citationStatistical genomics in rare cancer
Aghababazadeh, F. A., Mo, Q., & Fridley, B. L. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.021 · Cited by 26
Self-citationSystems Biology and Kidney Disease
Schaub, J. A., Hamidi, H., Subramanian, L., & Kretzler, M. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09990819 · Cited by 31
Patient-Specific Multi-Omics Models and the Application in Personalized Combination Therapy
John, A. J., Qin, B., Kalari, K. R., Wang, L., & Yu, J. (2020) · Future Oncology · doi:10.2217/fon-2020-0119 · Cited by 27
Multi-dimensional data integration algorithm based on random walk with restart
Wen, Y., Song, X., Yan, B., Yang, X., Wu, L., Leng, D., He, S., & Bo, X. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04029-3 · Cited by 27
DeFusion: a denoised network regularization framework for multi-omics integration
Wang, W., Zhang, X., & Dai, D. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab057 · Cited by 27
Multiomics Data Integration in Time Series Experiments
Tarazona, S., Balzano‐Nogueira, L., & Conesa, A. (2018) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2018.06.005 · Cited by 29
Liu, X., & Mei, X.-Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1156372 · Cited by 30
“, 2018) (Mo et al., 2013), patient stratification (S Khakabimamaghani et al.”
BackgroundWebber, J. T., Ranall, M. V., Kaushik, S., & Bandyopadhyay, S. (2018) · Cell Systems · doi:10.1016/j.cels.2018.10.001 · Cited by 26
Naderi, A. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12195 · Cited by 24
Separating common (global and local) and distinct variation in multiple mixed types data sets
Song, Y., Westerhuis, J. A., & Smilde, A. K. (2019) · Journal of Chemometrics · doi:10.1002/cem.3197 · Cited by 24
“Both of these approaches have already been generalized to discrete data sets [7, 8].”
BackgroundMultimodal Learning for Multi-omics: A Survey
Tabakhi, S., Suvon, M. N. I., Ahadian, P., & Lu, H. (2022) · World Scientific Annual Review of Artificial Intelligence · doi:10.1142/s2811032322500047 · Cited by 27
Multi-omics profiling approach in food allergy
Devonshire, A. L., Gautam, Y., Johansson, E., & Baye, T. M. (2023) · World Allergy Organization Journal · doi:10.1016/j.waojou.2023.100777 · Cited by 27
Integrated ‘omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes
Wolters, J. E. J., Breda, S. G. J. V., Grossmann, J., Fortes, C., Caiment, F., & Kleinjans, J. C. S. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.02.026 · Cited by 25
Ge, S., Liu, J., Cheng, Y., Meng, X., & Wang, X. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac500 · Cited by 26
Kim, H. I., Lee, H., Kim, T. H., Lee, J., Lee, S., & Lee, S.-J. (2015) · Oncotarget · doi:10.18632/oncotarget.5466 · Cited by 24
“Furthermore, integrative clustering [36] of copy number, DNA methylation, and mRNA expression data found six clusters (Figure 7) [30].”
BackgroundCWGCNA: an R package to perform causal inference from the WGCNA framework
Liu, Y. (2024) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqae042 · Cited by 31
“For multi-omics or single-omic clustering, the performance of CWGCNA was compared with the public tool iClusterPlus ( 23 ,24 ).”
MethodThingholm, L. B., Andersen, L. V. B., Makalic, E., Southey, M. C., Thomassen, M., & Hansen, L. L. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00002 · Cited by 23
“A study by Mo et al. further developed the iCluser tool to iCluster+ to allow inclusion of discrete variables from sequencing data (Mo et al., 2013).”
MethodWang, M., & Allen, G. I. (2019) · PubMed · doi:10.48550/arxiv.1912.05449 · Cited by 23
“In this subsection, we evaluate the performance of iGecco and (adaptive) iGecco+ on mixed multi-view data by comparing it with hierarchical clustering, iClusterPlus (Mo et al., 2013) and Bayesian Consensus Clustering (Lock and Dunson, 2013).”
MethodInfluentialMulti-omic integration by machine learning (MIMaL)
Dickinson, Q., Aufschnaiter, A., Ott, M., & Meyer, J. G. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac631 · Cited by 23
Newman, N. K., Macovsky, M. S., Rodrigues, R. R., Bruce, A. M., Pederson, J. W., Padiadpu, J., Shan, J., Williams, J., Patil, S. S., Dzutsev, A., et al. (2024) · Nature Protocols · doi:10.1038/s41596-024-00960-w · Cited by 25
“Additional R packages (e.g., MixOmics 28 , MOFA+ 29,30 and iClusterPlus 31,32 ) also use sophisticated statistical methods to combine multiple -omics data measured from the same patients.”
Kan, Z., Wen, J., Bonato, V., Webster, J., Yang, W., Ivanov, V., Kim, K. H., Roh, W., Liu, C., Mu, X. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55914-x · Cited by 29
Dong, X., Zhang, R., He, J., Lai, L., Alolga, R. N., Shen, S., Zhu, Y., You, D., Lin, L., Chen, C., et al. (2019) · Aging · doi:10.18632/aging.102189 · Cited by 21
“iCluster plus is a significant enhancement of the iCluster method, which integrates diverse data types and performs well in recognition of high- and lowmortality risk patterns [33].”
MethodGenomic analysis of head and neck cancer cases from two high incidence regions
Perdomo, S. P., Anantharaman, D., Foll, M., Abedi‐Ardekani, B., Durand, G., Rosa, L. A. R., Holmila, R. J., Calvez‐Kelm, F. L., Tajara, E. H., Wünsch‐Filho, V., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191701 · Cited by 21
Integrative Analyses of Cancer Data: A Review from a Statistical Perspective
Wei, Y. (2015) · Cancer Informatics · doi:10.4137/cin.s17303 · Cited by 21
Demirel, H. C., Arici, M. K., & Tunçbağ, N. (2021) · Molecular Omics · doi:10.1039/d1mo00158b · Cited by 29
Jeong, H.-H., Leem, S., Wee, K., & Sohn, K.-A. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0171-1 · Cited by 21
“Many computational attempts have been made to identify molecular abnormalities that affect clinical outcomes and therapeutic targets, by integrating multiple genomic profiles and clinical data [1–15].”
BackgroundDissecting cancer heterogeneity with a probabilistic genotype-phenotype model
Cho, D.-Y., & Przytycka, T. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt577 · Cited by 20
“Thus unlike pattern-discovery methods, such as iCLUSTER (26,27), which introduces hidden variables for subtype membership to associate genotypic variations with gene expression, our approach models the actual relation between putative genetic causes and expression phenotype.”
MethodKling, T., Johansson, P., Sánchez, J., Marinescu, V. D., Jörnsten, R. J., & Nelander, S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv413 · Cited by 21
“Another increasingly important challenge is to integrate molecular data from several different cancers to identify common vulnerabilities that can be exploited therapeutically (3,4).”
A review on multi-omics integration for aiding study design of large scale TCGA cancer datasets
Han, E., Kwon, H., & Jung, I. (2025) · BMC Genomics · doi:10.1186/s12864-025-11925-y · Cited by 22
“…imputing missing values offer considerable benefits within MOSD, allowing deeper insight into latent structures that span multiple data types. iClusterPlus iClusterPlus [49] is an advanced version of iCluster [50] that integrates multi-omics data using a probabilistic joint latent-variable model.”
A p-Median approach for predicting drug response in tumour cells
Fersini, E., Messina, E., & Archetti, F. (2014) · BMC Bioinformatics · doi:10.1186/s12859-014-0353-7 · Cited by 20
“Most of the multi-source clustering approaches follow one of the following paradigms: (a) clustering each data source separately to then ad-hoc integrate the separate clustering solutions [26,27] or (b) combining all data sources to determine a single “joint” clustering [28,29] as Traditional p-Median and Probabilisti…”
MethodA multiobjective multi-view cluster ensemble technique: Application in patient subclassification
Mitra, S., & Saha, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216904 · Cited by 20
PIntMF: Penalized Integrative Matrix Factorization method for multi-omics data
Pierre-Jean, M., Mauger, F., Deleuze, J.-F., & Le Floch, E. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btab786 · Cited by 20
“1 Simulations on independent datasets (non-correlated blocks) The performance of PIntMF to cluster samples and to select relevant variables was evaluated on simulated data described by Pierre-Jean et al. (2020). The framework of these simulations is composed of three blocks with three different types of distribution (…”
MethodConsensus clustering methodology to improve molecular stratification of non-small cell lung cancer
Manganaro, L., Bianco, S., Bironzo, P., Cipollini, F., Colombi, D., Corà, D., Corti, G., Doronzo, G., Errico, L., Falco, P., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33954-x · Cited by 23
“Specifically, we employed K-Means clustering 72 , spectral clustering 73 , hierarchical clustering 74 , iClusterPlus 14 , and SNF 75 , the first three methods being of general applicability, whereas the last two have been specifically designed for genomic data analysis.”
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
Zhao, X., Little, P., Hoyle, A. P., Pegna, G. J., Hayward, M. C., Ivanova, A., Parker, J. S., Marron, D. L., Soloway, M. G., Jo, H., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00584 · Cited by 20
“Rather, multiple genetic, and epigenetic aberrations within the cancer itself (42), the host (43), and the environment (44) may play an even larger role in established metastases as opposed to primary melanoma.”
BackgroundUzunangelov, V., Wong, C. K., & Stuart, J. M. (2020) · bioRxiv · doi:10.1371/journal.pcbi.1008878 · Cited by 13
Detecting molecular subtypes from multi-omics datasets using SUMO
Sienkiewicz, K., Chen, J., Chatrath, A., Lawson, J. T., Sheffield, N. C., Zhang, L., & Ratan, A. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100152 · Cited by 18
“More sophisticated methods (e.g., iCluster [Shen et al., 2009], iClusterPlus [Mo et al., 2013], and Bayesian consensus clustering [Lock and Dunson, 2013]) model the probabilistic distribution of each data type and infer subtypes by maximization of the likelihood of the observed data.”
Multimodal data integration in early-stage breast cancer
Llinas-Bertran, A., Butjosa-Espín, M., Barberi, V., & Seoane, J. A. (2025) · The Breast · doi:10.1016/j.breast.2025.103892 · Cited by 21
“Mo et al. (2013) leveraged iClusterPlus and recapitulated ERBB2 amplification as a driver of alterations in breast cancer cell lines [60].”
Melamed, R., Wang, J., Iavarone, A., & Rabadán, R. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv026 · Cited by 20
“Combinations of genes have been found to jointly predict cancer phenotype (Varadan and Anastassiou, 2006; Mo et al., 2013), but, to our knowledge, no unsupervised method exists for finding related genetic alterations.”
BackgroundPractical aspects of NGS-based pathways analysis for personalized cancer science and medicine
Kotelnikova, E. A., Pyatnitskiy, M. A., Paleeva, A. G., Kremenetskaya, O. S., & Vinogradov, D. V. (2016) · Oncotarget · doi:10.18632/oncotarget.9370 · Cited by 19
“While several algorithms have been developed such as GSAA [183], iCluster+ [184] and GSOA [185], most of them are designed to deal with a cohort of samples and require large training sets.”
MethodTendon and multiomics: advantages, advances, and opportunities
Sarmiento, P., & Little, D. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00168-6 · Cited by 19
Cai, M., & Li, L. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0306-x · Cited by 19
“For example, [1] proposes a framework for joint modeling of discrete and continuous variables that arise from integrated genomic, epigenomic, and transcriptomic profiling which is applied on distinct integrated tumor subtypes discovery.”
BackgroundIntegrative omics analysis. A study based on Plasmodium falciparum mRNA and protein data
Tomescu, O. A., Mattanovich, D., & Thallinger, G. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-s2-s4 · Cited by 18
“Mo and colleagues [5] describe integrative clustering of genomic, epigenomic and transcriptomic profiling.”
BackgroundMartini, P. G. V., Chiogna, M., Calura, E., & Romualdi, C. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz324 · Cited by 18
“However, these are focused mainly for two-class comparison and for identification of cancer subtypes (not necessarily different prognoses) (15–21).”
A Novel Method for Cancer Subtyping and Risk Prediction Using Consensus Factor Analysis
Tran, D., Nguyen, H., Le, U. Q., Bebis, G. N., Luu, H. N., & Nguyen, T. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01052 · Cited by 18
“Methods in the second category (statistical modeling) include BCC (34), MDI (35), iClusterBayes (36), iClusterPlus (37), and iCluster (38, 39).”
Clinical Genomics: Challenges and Opportunities
Vijay, P., McIntyre, A. B. R., Mason, C. E., Greenfield, J. P., & Li, S. (2016) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2016015724 · Cited by 18
Systems Biology Approaches Toward Understanding Primary Mitochondrial Diseases
Maldonado, E. M., Taha, F. A., Rahman, J., & Rahman, S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00019 · Cited by 19
Representation Learning for the Clustering of Multi-Omics Data
Viaud, G., Mayilvahanan, P., & Cournède, P.-H. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3060340 · Cited by 17
“…Factorization [6] decomposes non-negative input source matrices into non-negative loadings and factors, the latter being common across sources, while iCluster [7] and its extension iCluster+ [8] also decomposes source matrices into loadings and factors but without the need for non-negativity.”
BackgroundJiang, Z., Cheng, L., Wu, Z., Zhou, L., Wang, H., Hong, Q., Wu, Q., Long, Y., Huang, Y., Xu, G., et al. (2022) · EMBO Reports · doi:10.15252/embr.202154275 · Cited by 17
“…formed by integrating various molecular platforms of iHCC, we utilized iCluster, which formulates the problem of subgroup discovery as a joint multivariate regression of multiple data types with reference to a set of common latent variables that represent the underlying tumor subtypes (Mo et”
Statistical Methods for Integrative Clustering of Multi-omics Data
Chalise, P., Kwon, D., Fridley, B. L., & Mo, Q. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2986-4_5 · Cited by 18
Self-citationDeciphering gastric inflammation-induced tumorigenesis through multi-omics data and AI methods
Zhang, Q., Yang, M., Zhang, P., Wu, B., Wei, X., & Li, S. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0129 · Cited by 17
“Mo et al. 53 have proposed a flexible matrix decomposition structure that uses the EM algorithm to analyze the regularized clustering structures among structural data and the intrinsic connections in multi-level data.”
BackgroundMethodShakyawar, S. K., Sajja, B. R., Patel, J. C., & Guda, C. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbae015 · Cited by 17
“The omics cohorts of large numbers of patients have improved our understanding of the molecular basis of cancer diagnosis, prognosis, and subtyping (Gao and Church 2005, Mo et al. 2013, Menyh � art and Gy } orffy 2021, He et al. 2023, Li et al. 2023).”
BackgroundMethodLiu, J., Gao, Y.-L., Zheng, C.-H., Xu, Y. D., & Yu, J. (2016) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2016.2574923 · Cited by 17
“improve identification performance of the aberrations of tumor genes as numerous other studies have shown this by using genomic data [9], [23], [24].”
BackgroundStepwise iterative maximum likelihood clustering approach
Sharma, A. K., Shigemizu, D., Boroevich, K. A., López, Y., Kamatani, Y., Kubo, M., & Tsunoda, T. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1184-5 · Cited by 17
“In the most recent multi-omics data analysis tools, like iCluster, and iClusterPlus [1], the underlying clustering method used was also k -means.”
MethodChi, C., Ye, Y., Chen, B., & Huang, H. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab143 · Cited by 17
Novel cancer subtyping method based on patient-specific gene regulatory network
Nakazawa, M. A., Tamada, Y., Tanaka, Y., Ikeguchi, M., Higashihara, K., & Okuno, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-02394-w · Cited by 17
Fast tree aggregation for consensus hierarchical clustering
Hulot, A., Chiquet, J., Jaffrézic, F., & Rigaill, G. J. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3453-6 · Cited by 17
“…consisting in a preprocessing of the original data set before concatenation into a single data set ready for some standard clustering analysis [12, 13]; ii ) regulatory integrative clustering, which are based on pathways [14]; iii ) clustering of clusters, i.e., methods that take clustering…”
MethodFrom multi-omics to predictive biomarker: AI in tumor microenvironment
Hai, L., Jiang, Z., Zhang, H., & Sun, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1514977 · Cited by 21
Bao, J., Chang, C., Zhang, Q., Saykin, A. J., Shen, L., Long, Q., & Initiative, F. T. A. D. N. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad073 · Cited by 16
“Later, Mo et al. [24] extended the iCluster to the iCluster + framework by allowing the simultaneous integration of continuous and discrete datasets.”
BackgroundMethod
Metadata
- Authors
- Mo, Q., Wang, S., Seshan, V. E., Olshen, A. B., Schultz, N., Sander, C., Powers, R. S., Ladanyi, M., & Shen, R.
- Affiliations
- Baylor College of Medicine (US)
- University of Wisconsin–Madison (US)
- Department of Epidemiology and Biostatistics,
- University of California, San Francisco (US)
- Computational Biology Program, and
- Cancer Genome Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11797
- Memorial Sloan Kettering Cancer Center (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-02-21
- Volume
- 110
- Issue
- 11
- Pages
- 4245-4250
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3600490
- OpenAlex
- W2023461603
- Cited by
- 474
- References
- 36
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 34 · 2023: 54 · 2022: 40 · 2021: 74 · 2020: 40 · 2019: 48 · 2018: 27 · 2017: 27 · 2016: 25 · 2015: 23 · 2014: 13 · 2013: 7
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (U24CA143840, CA143840, U01CA168409, P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- tumor subtypes, cancer driver genes, integrative clustering, somatic mutations, copy number alterations, gene expression, Cancer Cell Line Encyclopedia, TCGA, colorectal cancer, breast cancer, cancer subtyping, cell of origin
- MeSH terms
- Breast Neoplasms, Female, Gene Expression Regulation, Humans, Male, Colorectal Neoplasms, Genomics, Databases, Genetic, Genes, Neoplasm, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review